UB translational researchers are developing a richer understanding of how "bad" cholesterol causes atherosclerosis in humans, revealing a key role for stem cells.
UB researcher Sheldon Park has received a National Science Foundation grant to develop technology that dramatically reduces the time it takes to characterize proteins.
A UB study that would examine the effects of emissions from the Tonawanda Coke plant is being recommended for funding with fines expected to be levied against the company by a federal judge.
A new gonorrhea treatment, based on an anti-cancer therapy developed by a Buffalo startup company, has successfully eliminated gonococcal infection in female mice and prevented reinfection, according to research by UB scientists.
UB chemistry professor Jochen Autschbach is a co-author of a paper in Science Express that reports a major breakthrough regarding the properties of a catalyst that chemists have been seeking for decades.
The first proteomic analysis of an animal model of a rare, sometimes deadly birth defect has revealed that the molecular mechanisms that cause it are more complex than previously understood.
